Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
出版年份 2021 全文链接
标题
Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
作者
关键词
Prodrug, Nanoparticle, Dasatinib, Cisplatin
出版物
Asian Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-09-08
DOI
10.1016/j.ajps.2021.08.001
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery
- (2020) Zhiren Wang et al. Acta Biomaterialia
- Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy
- (2020) Yixuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy
- (2020) Xiaoxu Zhang et al. ACS Biomaterials-Science & Engineering
- Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells
- (2019) Ling Ma et al. CANCER BIOLOGY & THERAPY
- pH/redox dual-sensitive platinum (IV)-based micelles with greatly enhanced antitumor effect for combination chemotherapy
- (2019) Le He et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Self-Assembled Responsive Bilayered Vesicles with Adjustable Oxidative Stress for Enhanced Cancer Imaging and Therapy
- (2019) Jibin Song et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Efficient Click Synthesis of Protonize & Reduction-Sensitive Amphiphilic Small Molecule Prodrug Containing Camptothecin and Gemcitabine for Drug Self-Delivery System
- (2019) Shuxiang Dong et al. MOLECULAR PHARMACEUTICS
- Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
- (2019) Quan Zhou et al. Nature Nanotechnology
- Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release
- (2018) Pengkai Ma et al. ACS Applied Materials & Interfaces
- Dual Drug Backboned Shattering Polymeric Theranostic Nanomedicine for Synergistic Eradication of Patient-Derived Lung Cancer
- (2018) Yuwei Cong et al. ADVANCED MATERIALS
- Facile Fabrication of 10-Hydroxycamptothecin-Backboned Amphiphilic Polyprodrug with Precisely Tailored Drug Loading Content for Controlled Release
- (2018) Xiaolong Zhang et al. BIOCONJUGATE CHEMISTRY
- High Drug Loading and Sub-Quantitative Loading Efficiency of Polymeric Micelles Driven by Donor–Receptor Coordination Interactions
- (2018) Shixian Lv et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy
- (2018) Lulu Fan et al. MOLECULAR PHARMACEUTICS
- Multifunctional Cargo-Free Nanomedicine for Cancer Therapy
- (2018) Ying Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Amphiphilic Drug Conjugates as Nanomedicines for Combined Cancer Therapy
- (2018) Chuang Gao et al. BIOCONJUGATE CHEMISTRY
- Green Mass Production of Pure Nanodrugs via an Ice-Template-Assisted Strategy
- (2018) Jinfeng Zhang et al. NANO LETTERS
- Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy
- (2017) Jingjing Sun et al. JOURNAL OF CONTROLLED RELEASE
- Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy
- (2017) Shuting Xu et al. JOURNAL OF CONTROLLED RELEASE
- Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy
- (2017) Wenxiu He et al. Advanced Healthcare Materials
- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways
- (2015) Jie Chen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Improved Angiostatic Activity of Dasatinib by Modulation with Hydrophobic Chains
- (2015) Emilia Păunescu et al. ACS Medicinal Chemistry Letters
- Thermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
- (2014) Wenjia Shen et al. BIOMACROMOLECULES
- Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
- (2014) Ping Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells
- (2013) Elizabeth M.H. Kim et al. JOURNAL OF SURGICAL RESEARCH
- Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib
- (2011) Li Wang et al. CLINICAL SCIENCE
- Dasatinib: An Anti-Tumour Agent via Src Inhibition
- (2011) Antonio Gnoni et al. CURRENT DRUG TARGETS
- Prodrugs--from Serendipity to Rational Design
- (2011) K. M. Huttunen et al. PHARMACOLOGICAL REVIEWS
- Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
- (2010) John Araujo et al. CANCER TREATMENT REVIEWS
- Excursions in polynuclear platinum DNA binding
- (2010) John B. Mangrum et al. CHEMICAL COMMUNICATIONS
- Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment
- (2010) W. Liang et al. CLINICAL CANCER RESEARCH
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
- (2010) E. L. Mayer et al. CLINICAL CANCER RESEARCH
- Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery
- (2010) Youqing Shen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin
- (2009) P. Ceppi et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started